ELIXIR-CONVERGE D8.1 Access to EU tools and project data

Rich and integrated biomolecular data are essential to support the world's scientific research into COVID-19. These data underlie our biological understanding (viral biology, the infection processes and patient response), our ability to identify and track COVID-19 (epidemiology and viral spread) and our capacity to intervene (through public health, therapeutic and vaccine approaches).

An early priority of the European COVID-19 Data Platform has been to bring together relevant biomolecular data and the scholarly literature describing these data along with tools, standards and other resources to support operations upon the data.

In this deliverable, we report on content-building activities within the Platform that serve, through the COVID-19 Data Portal, to make discoverable and accessible biomolecular data, literature and collections (tools, standards and related resources) relating to COVID-19 (https://www.covid19dataportal.org/).

Our content building has resulted to date in over 420,000 biomolecular data records, almost 110,000 literature records and 57 linked collections covering tools, standards and other resources. Data continue to grow in number and diversity.

This content has seen heavy exposure to users and two use cases around drug development and bioinformatics illustrate impact.Our work builds upon and demonstrates the important foundations that are provided by well-managed biomolecular data and shows the potential of these data rapidly to be deployed to support urgent scientific challenges.